Synthetic approaches to 1,2,4-triazolo[5,1-c][1,2,4]triazin-7-ones as basic heterocyclic structures of the antiviral drug Riamilovir ("Triazavirin®") active against SARS-CoV-2 (COVID-19) / G. A. Artem'ev, V. L. Rusinov, D. S. Kopchuk [et al.] // Organic & Biomolecular Chemistry. – 2022. – Vol. 20, No. 9. – P. 1828-1837.